Request Appointment
525 E 68th St# 94New York, NY 10065
Fax+1 212-746-8197
Overview of Dr. Scherr
Dr. Douglas Scherr is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from George Washington University School of Medicine and has been in practice 23 years. He specializes in surgical oncology and is experienced in prostate cancer, gynecologic oncology, urogynecology and pelvic reconstructive surgery, pediatric urology, and urologic oncology.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2000 - 2002
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1996 - 2000
George Washington UniversityResidency, Surgery, 1994 - 1996- George Washington University School of Medicine and Health SciencesClass of 1994
Certifications & Licensure
NY State Medical License 1996 - 2027
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2017
Clinical Trials
- Use of Multiphoton Microscopy in the Diagnosis of Cancer Start of enrollment: 2005 Jun 01
- Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Start of enrollment: 2009 Sep 01
- Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates.Juan Carlos Angulo-Lozano, Alejandro Calvillo-Ramirez, Andres Noyola-Perez, Gabriel Cojuc-Konigsberg, Hector Vaquera-Alfaro
Current Urology Reports. 2026-04-11 - Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer.Nicholas W Eyrich, Yijian Huang, Yingye Zheng, John Wei, Lori Sokoll
JU Open Plus. 2026-02-01 - Persistent Sex Disparities in Bladder Cancer Diagnosis: An Analysis of National Trends From 2012 to 2021.Edward Z Zhang, Jack C Millot, Adithya Balasubramanian, Laura Davis, Gal Wald
Urology Practice. 2026-01-01
Press Mentions
A Disturbing Rise in Prostate CancerApril 1st, 2023- Risk Stratification of Upper Tract Urothelial Carcinoma - Doug ScherrAugust 27th, 2021
Doctors Can Now Detect Hard-to-Diagnose Prostate CancerAugust 9th, 2012
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPOGHI PPO
Great West PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
